News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
DOVEY BRIAN H
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/13/2019 |
3
| DP VIII Associates, L.P. (10% Owner) has filed a Form 3 on Alliqua BioMedical, Inc. |
05/13/2019 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on Alliqua BioMedical, Inc. |
08/21/2018 |
3
| DP VIII Associates, L.P. (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
08/21/2018 |
3
| DOMAIN ASSOCIATES (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
08/21/2018 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
10/05/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
10/05/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
03/02/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
03/02/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
03/02/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
03/02/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
03/02/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
10/29/2013 |
3
| DOVEY BRIAN H (10% Owner) has filed a Form 3 on VERACYTE, INC. |
07/16/2013 |
3
| DOVEY BRIAN H (10% Owner) has filed a Form 3 on Ocera Therapeutics, Inc. |
06/25/2013 |
3
| DOVEY BRIAN H (10% Owner) has filed a Form 3 on Esperion Therapeutics, Inc. |
01/15/2013 |
3
| DOVEY BRIAN H (10% Owner) has filed a Form 3 on Celator Pharmaceuticals Inc |
11/15/2011 |
3
| DOVEY BRIAN H (10% Owner) has filed a Form 3 on Clovis Oncology, Inc. |
11/22/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
11/15/2010 |
3
| DOVEY BRIAN H (10% Owner) has filed a Form 3 on REVA Medical, Inc. |
08/23/2010 |
3
| DOVEY BRIAN H (10% Owner) has filed a Form 3 on ACHILLION PHARMACEUTICALS INC |
04/21/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|